丰明乾
Supervisor of Doctorate Candidates
Supervisor of Master's Candidates
Name (Simplified Chinese):丰明乾
Name (Pinyin):fengmingqian
Professional Title:Professor
Education Level:With Certificate of Graduation for Doctorate Study
Degree:博士
E-Mail:
Alma Mater:南京大学
Teacher College:College of Life Sciences & Technology
School/Department:生命科学技术学院
Other Contact Information:
PostalAddress：
OfficePhone：
Email：
Scientific Research
Current position:
Home
>
Scientific Research
Research Field
- No content
MORE>
Paper Publications
- Gao W, Tang Z, Zhang YF, Feng M, Qian M, Dimitrov DS, Ho M. Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis. Nat Commun. 2015, 6:6536.
- Feng M, Gao W, Wang R, Chen W, Man Y, Fig WD, Wang X, Dimitrov DS, and Ho M. Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proc Nat Sci Acad USA. 2013, 110:E1083-91..
- Feng M, Ho M. Glypican-3 antibodies: a new therapeutic target for liver cancer. FEBS Lett. 2014, 588:377-82..
- Gao W, Kim H, Feng M, Phung Y, Xavier CP, Rubin JS, Ho M. Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy. Hepatology, 2014, 60:576-87.
- Tang Z, Feng M, Gao W, Phung Y, Chen W, Chaudhary A, St Croix B, Qian M, Dimitrov DS, and Ho M. A human single-domain antibody elicits potent anti-tumor activity by targeting an epitope in mesothelin close to the cancer cell surface. Mol Cancer Ther, 2013, 12: 416-26..
Patents
- Mesothelin antibodies and methods for eliciting potent antitumor activity. U.S. PCT/US2013/059883. Inventors: Ho M, Pastan I, Dimitrov DS, Tang Z, Feng M, and Gao W
- Human monoclonal antibodies specific for glypican-3 and use thereof. PCT application no. PCT/US2012/034186; International filling date 19/Apr/2012. Inventors: Ho M,Feng M, Gao W, Kim H, and Dimiter D.
Published Books
- No content
Research Projects
